Related Experiment Videos
Hyperparathyroidism and subsequent cancer risk in Denmark
Amy L Pickard1, Gloria Gridley, Lene Mellemkjae
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Carrboro, North Carolina, USA.
Cancer
|October 5, 2002
Summary
Hyperparathyroidism (HPT) is linked to increased cancer risk, particularly hematopoetic, thyroid, and urinary tract carcinomas. Further research is needed to understand the endocrine factors influencing these risks.
Area of Science:
- Endocrinology
- Oncology
- Epidemiology
Background:
- Hyperparathyroidism (HPT) is characterized by elevated serum calcium levels.
- Emerging evidence suggests an association between HPT and various malignancies.
- This association implies a potential causal link between HPT and cancer development.
Purpose of the Study:
- To investigate the relationship between HPT and the risk of developing subsequent cancers.
- To quantify the cancer risk associated with HPT using a large patient cohort.
Main Methods:
- A record-linkage study was conducted using Danish hospital discharge records from 1977-1993.
- 2425 patients diagnosed with HPT were identified and linked to the Danish National Cancer Registry.
- Standardized Incidence Ratios (SIRs) were calculated to estimate cancer risk.
Main Results:
- An overall increased cancer risk was observed (SIR, 1.25), with higher risk in women.
- Primary HPT was significantly associated with elevated hematopoetic malignancies (SIR, 1.88), including multiple myeloma.
- Other/unspecified HPT types showed significant increases in urinary tract carcinoma (SIR, 2.71) and thyroid carcinoma (SIR, 21.19).
Conclusions:
- Specific endocrine alterations in HPT may influence long-term cancer risk.
- Further monitoring is recommended for hematopoetic, thyroid, and urinary tract carcinomas in HPT patients.
- Understanding these links can inform future cancer prevention and management strategies.